Friday, July 10, 2026

biotech · NSCLC Stage IV · Poliomyelitis

BioMarin Pharmaceutical

Biotech Pharmaceutical Co is a biotech organization headquartered in CN. Primary therapeutic focus areas include NSCLC Stage IV, Poliomyelitis, Hyperlipidemias, Non-Hodgkin Lymphoma, Hepatocellular Carcinoma (HCC). NovaP

770 Lindaro Street, San Rafael, CA 94901, US HQ
1997 Founded
3,171 Employees
NMPA registrant Type
Company details
Status
Public
HQ
770 Lindaro Street, San Rafael, CA 94901, US
Founded
1997
Employees
3,171
Programs
40
Drugs
37
Patents
0
Clinical program

CD19-TriCAR-T/SILK

Phase 1 · mab · Non-Hodgkin Lymphoma

CD19-TriCAR-T/SILK for Non-Hodgkin Lymphoma is a Phase 1 program (mab) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Internal code 2018-127

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Biotech Pharmaceutical Co.,
Phase
Phase 1
Modality
mab
Indication
Non-Hodgkin Lymphoma
Status
active
Trials
1

Clinical trials